NICE has called for more evidence from Boehringer Ingelheim on its drug empagliflozin for treating type 2 diabetes in new draft guidance.
28 August 2014
In final guidance, the National Institute for Health and Care Excellence (NICE) has recommended the use of Biogen Idec’s multiple sclerosis drug, dimethyl fumarate (also called Tecfidera).
27 August 2014
A procedure to cure a painful mouth disorder, which involves replacing part of the jaw, has been judged safe and effective by NICE. The guidance is the 500th piece of interventional procedures guidance to be published by the institute.
26 August 2014